{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:28:39Z","timestamp":1764732519953},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.genhosppsych.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T04:46:21Z","timestamp":1380948381000},"page":"126.e1-126.e2","source":"Crossref","is-referenced-by-count":17,"title":["Escitalopram-induced Parkinsonism"],"prefix":"10.1016","volume":"36","author":[{"given":"Serta\u00e7","family":"Ak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Elif An\u0131l","family":"Ya\u011fc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.genhosppsych.2013.09.010_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01250091","article-title":"Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant","volume":"45","author":"Meltzer","year":"1979","journal-title":"J Neural Transm"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.09.010_bb0010","first-page":"148","article-title":"Extrapyramidal symptoms associated with antidepressants\u2013a review of the literature and an analysis of spontaneous reports","volume":"22","author":"Madhusoodanan","year":"2010","journal-title":"Ann Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.09.010_bb0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004714-199710000-00007","article-title":"Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses","volume":"17","author":"Gill","year":"1997","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.09.010_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004850-200203000-00006","article-title":"Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case control study using spontaneous reports","volume":"17","author":"Schillevoort","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.09.010_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/026988119801200212","article-title":"SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment","volume":"12","author":"Lane","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2013.09.010_bb0030","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM IV)","author":"American Psychiatric Association (APA)","year":"1994"},{"key":"10.1016\/j.genhosppsych.2013.09.010_bb0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/ajp.152.1.122","article-title":"Fluoxetine and extrapyramidal side effects","volume":"152","author":"Coulter","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.09.010_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.870130605","article-title":"Young-onset Parkinson's disease revisited\u2013clinical features, natural history, and mortality","volume":"13","author":"Schrag","year":"1998","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.09.010_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0303-8467(02)00027-6","article-title":"Environmental risk factors of young onset Parkinson's disease: a case\u2013control study","volume":"104","author":"Tsai","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.09.010_bb0055","first-page":"134","article-title":"Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease","volume":"15","author":"Brajkovic","year":"2012","journal-title":"Hell J Nucl Med"},{"issue":"7","key":"10.1016\/j.genhosppsych.2013.09.010_bb0060","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.pnpbp.2006.03.002","article-title":"Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report","volume":"30","author":"Elvan","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.09.010_bb0065","first-page":"315","article-title":"The relationship of selective serotonin reuptake inhibitors with Parkinson\u2019s disease and Parkinsonism: two case reports","volume":"12","author":"Taycan","year":"2011","journal-title":"Anadolu Psikiyatri Derg"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.09.010_bb0070","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/syn.20954","article-title":"Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra","volume":"65","author":"MacGillivray","year":"2011","journal-title":"Synapse"},{"issue":"8","key":"10.1016\/j.genhosppsych.2013.09.010_bb0075","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1212\/01.wnl.0000302255.49113.51","article-title":"Understanding drug-induced parkinsonism: separating pearls from oy-sters","volume":"70","author":"Alvarez","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.09.010_bb0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/WNF.0b013e318210ea3e","article-title":"Citalopram-induced Parkinsonian syndrome: case report","volume":"34","author":"Mileti\u0107","year":"2011","journal-title":"Clin Neuropharmacol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834313002570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834313002570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T22:55:22Z","timestamp":1646693722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834313002570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0163834313002570"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.09.010","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}